HomeALM • BME
add
Almirall SA
Previous close
€12.68
Day range
€12.46 - €12.64
Year range
€8.03 - €12.82
Market cap
2.73B EUR
Avg Volume
128.96K
P/E ratio
125.51
Dividend yield
1.46%
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change | 
|---|---|---|
| Revenue | 277.27M | 10.35% | 
| Operating expense | 232.48M | 12.88% | 
| Net income | 4.98M | -37.68% | 
| Net profit margin | 1.80 | -43.40% | 
| Earnings per share | — | — | 
| EBITDA | 39.04M | -25.03% | 
| Effective tax rate | 40.20% | — | 
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change | 
|---|---|---|
| Cash and short-term investments | 323.22M | -2.31% | 
| Total assets | 2.31B | -0.58% | 
| Total liabilities | 844.82M | 1.20% | 
| Total equity | 1.46B | — | 
| Shares outstanding | 214.79M | — | 
| Price to book | 1.86 | — | 
| Return on assets | 0.95% | — | 
| Return on capital | 1.21% | — | 
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change | 
|---|---|---|
| Net income | 4.98M | -37.68% | 
| Cash from operations | 31.15M | -27.41% | 
| Cash from investing | -58.13M | 16.98% | 
| Cash from financing | -24.47M | -212.31% | 
| Net change in cash | -51.45M | -47.23% | 
| Free cash flow | -87.74M | -11.43% | 
About
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Founded
1944
Website
Employees
2,084
